pd 173074 has been researched along with B-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotani, N | 1 |
| Ishiura, Y | 1 |
| Yamashita, R | 1 |
| Ohnishi, T | 1 |
| Honke, K | 1 |
1 other study available for pd 173074 and B-Cell Lymphoma
| Article | Year |
|---|---|
Fibroblast growth factor receptor 3 (FGFR3) associated with the CD20 antigen regulates the rituximab-induced proliferation inhibition in B-cell lymphoma cells.
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Caspase 3; Cell Cycle | 2012 |